PMID: 42487666

Personalization of incretin therapy: can GLP-1 and GIP receptor polymorphisms influence therapy response?

La Vignera Sandro, Condorelli Rosita A

Journal of the Endocrine Society · 2026

Vol. 10, Issue 8, pp. bvag149

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.